/

Other

/

Vanda Pharmaceuticals

Vanda Pharmaceuticals

Vanda Pharmaceuticals

Verified Nov 2026

Other

·

United States flag

Washington, District of Columbia

·

Since 2003

Vanda Pharmaceuticals is a biopharmaceutical company headquartered in Washington, D.C., founded in 2003, with 500–1,000 employees and estimated annual revenue of $100–250 million. The company develops and commercializes therapies for central nervous system disorders and rare diseases. Its approved portfolio includes HETLIOZ for sleep-wake disorders, Fanapt for bipolar disorder and schizophrenia, PONVORY for multiple sclerosis, and NEREUS for motion-induced vomiting.

Vanda Pharmaceuticals

Verified Nov 2026

AT A GLANCE

Founded

2003

Headquarters

United States flag

Washington, District of Columbia

Employees

500-1,000

Ownership

Vanda Pharmaceuticals at a glance

Revenue

$100-250M

Est. band

Employees

500-1,000

Founded

2003

Headquarters

Washington, District of Columbia

Industries

Automotive

Electric Vehicles

Medical

Overview

Vanda Pharmaceuticals is a biopharmaceutical company headquartered in Washington, D.C., founded in 2003, with 500–1,000 employees and estimated annual revenue of $100–250 million. The company develops and commercializes therapies for central nervous system disorders and rare diseases. Its approved portfolio includes HETLIOZ for sleep-wake disorders, Fanapt for bipolar disorder and schizophrenia, PONVORY for multiple sclerosis, and NEREUS for motion-induced vomiting.

At a glance

Attribute

Detail

Founded

2003

Headquarters

Washington, District of Columbia

Employees

500-1,000

Revenue

$100-250M (estimated)

What Vanda Pharmaceuticals makes

The company advances clinical-stage candidates including Tradipitant for COVID-19 pneumonia and Bysanti for mood disorders, supported by research in genetics and drug discovery.

Latest developments

Company details

Vanda serves patients globally and maintains a focus on improving outcomes in unmet medical needs within neurology and rare disease treatment. Vanda Pharmaceuticals was founded in 2003, has an estimated 500-1,000 employees, and is headquartered in Washington, District of Columbia.

Frequently asked questions

What does Vanda Pharmaceuticals do?

Vanda Pharmaceuticals is a biopharmaceutical company headquartered in Washington, D.C., founded in 2003, with 500–1,000 employees and estimated annual revenue of $100–250 million. The company develops and commercializes therapies for central nervous system disorders and rare diseases. Its approved portfolio includes HETLIOZ for sleep-wake disorders, Fanapt for bipolar disorder and schizophrenia, PONVORY for multiple sclerosis, and NEREUS for motion-induced vomiting.

Where is Vanda Pharmaceuticals headquartered?

Vanda Pharmaceuticals is headquartered in Washington, District of Columbia (2200 Pennsylvania Avenue Northwest, Washington, District of Columbia, 20037).

When was Vanda Pharmaceuticals founded?

Vanda Pharmaceuticals was founded in 2003.

How big is Vanda Pharmaceuticals?

Vanda Pharmaceuticals has an estimated 500-1,000 employees, with revenue in the $100-250M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Washington, District of Columbia (HQ)Headquarters · United States
Washington, District of Columbia (HQ)2200 Pennsylvania Avenue Northwest, Washington, District of Columbia, 20037, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.